Atossa Therapeutics, Inc. (ATOS)
NASDAQ: ATOS · IEX Real-Time Price · USD
1.250
-0.030 (-2.34%)
Jul 12, 2024, 1:11 PM EDT - Market open

Atossa Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year
20232022202120202019 2018 - 2010
Net Income
-30.09-26.96-20.61-22.33-17.24
Upgrade
Depreciation & Amortization
0.020.010.020.050.05
Upgrade
Share-Based Compensation
4.626.795.273.028.84
Upgrade
Other Operating Activities
4.51-0.6-1.163.19-0.79
Upgrade
Operating Cash Flow
-20.94-20.76-16.47-11.57-9.13
Upgrade
Capital Expenditures
-0.01-0.03-0.01-0.01-0.01
Upgrade
Change in Investments
0-4.7000
Upgrade
Investing Cash Flow
-0.01-4.73-0.01-0.01-0.01
Upgrade
Share Issuance / Repurchase
-1.480113.8833.6211.34
Upgrade
Other Financing Activities
---0.574.93-
Upgrade
Financing Cash Flow
-1.480113.338.5511.34
Upgrade
Net Cash Flow
-22.43-25.4996.8226.972.2
Upgrade
Free Cash Flow
-20.96-20.79-16.48-11.58-9.14
Upgrade
Free Cash Flow Per Share
-0.17-0.16-0.14-1.02-1.07
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).